NEWS RELEASES

The information contained in each news release on this page was factually accurate on the date it was issued and posted. 

Sutro Biopharma Announces Proposed Public Offering

South San Francisco, Calif., May 11, 2020 -- Sutro Biopharma, Inc. (Nasdaq: STRO), a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF®, to create a broad...

read more